California 2017-2018 Regular Session

California Assembly Bill ACR156

Introduced
1/17/18  
Introduced
1/17/18  
Refer
1/22/18  
Refer
1/22/18  
Engrossed
1/29/18  
Engrossed
1/29/18  
Refer
1/30/18  
Refer
1/30/18  
Enrolled
2/20/18  
Enrolled
2/20/18  
Chaptered
2/22/18  
Chaptered
2/22/18  
Passed
2/22/18  

Caption

Chronic Traumatic Encephalopathy Awareness Day.

Impact

The passage of ACR156 underscores the urgent need for public awareness regarding CTE, a condition that has historically been underacknowledged despite its serious implications. By fostering education on CTE, this resolution may influence future legislation aimed at improving safety protocols in contact sports, enhancing risk assessments, and promoting mental health resources for those affected. The resolution does not carry statutory weight but serves to elevate the public discourse on an important health issue and could catalyze further action from lawmakers and health organizations.

Summary

Assembly Concurrent Resolution 156 (ACR156) officially designates January 30, 2018, as Chronic Traumatic Encephalopathy Awareness Day in California. This resolution aims to recognize and amplify the efforts of advocacy groups, particularly the Faces of CTE, in educating the public on the causes and dangers associated with Chronic Traumatic Encephalopathy (CTE). By proclaiming this awareness day, the bill seeks to highlight the significance of understanding this degenerative brain disease and its impacts on individuals, particularly athletes.

Sentiment

The sentiment surrounding ACR156 is generally positive, with a strong consensus among lawmakers regarding the need for increased awareness of CTE. The measure has received unanimous support, reflecting a shared understanding of the importance of addressing this health crisis. Advocacy groups and healthcare professionals have also expressed approval, as such initiatives are pivotal in educating families involved in youth sports and ensuring proper care for individuals displaying symptoms of CTE.

Contention

While there has been broad agreement on the need for awareness of CTE, there are underlying tensions regarding how to effectively address the issue through policy. Some advocates worry that simply declaring an awareness day may not suffice in addressing the systemic problems related to brain health and safety in sports. Moreover, discussions around funding for research into earlier diagnostic tools and better treatment options continue to be points of contention among stakeholders, indicating that while awareness is critical, more action-oriented policies will be necessary to achieve substantial progress.

Companion Bills

No companion bills found.

Previously Filed As

CA AB3047

Youth athletics: chronic traumatic encephalopathy.

CA SCR98

Traumatic Brain Injury Awareness Month.

CA SCR162

Alzheimer’s and Brain Awareness Month and The Longest Day.

CA SR49

Relative to veterans post-traumatic stress disorder awareness.

CA SCR141

Mental Health Awareness Month.

CA ACR103

Valley Fever Awareness Month.

CA ACR122

Maternal Health Awareness Day.

CA SCR138

Parkinson’s Awareness Month.

CA ACR170

Lyme Disease Awareness Month.

CA ACR204

Alzheimer’s Disease and Brain Awareness Month and The Longest Day.

Similar Bills

WV SB615

Requiring certain health insurance providers cover treatment for certain pediatric autoimmune neuropsychiatric disorders

CA AB1348

Youth athletics: chronic traumatic encephalopathy.

CA AB3047

Youth athletics: chronic traumatic encephalopathy.

WV SB297

Requiring coverage for certain pediatric autoimmune neuropsychiatric disorders in certain circumstances

WV SB45

Requiring coverage of treatment for certain pediatric autoimmune neuropsychiatric disorders in certain circumstances

IA SF242

A bill for an act relating to health insurance coverage for specified pediatric autoimmune neuropsychiatric disorders and postinfectious autoimmune encephalopathy.

IA SF288

A bill for an act relating to health insurance coverage for specified pediatric autoimmune neuropsychiatric disorders and postinfectious autoimmune encephalopathy.

WV SB236

Requiring coverage of treatment for certain pediatric autoimmune neuropsychiatric disorders in certain circumstances